Time’s almost up to register for Eyes On Retina 2026!
From AMD and diabetic eye disease to arterial occlusions, choroidal tumors, and pediatric retina, Eyes On Retina 2026 covers the full spectrum of retina care in one day. Attend 8 clinical sessions from leading experts live on Saturday, October 17, all built around the latest treatment and imaging protocols. Plus, earn up to 5 CE/CME credits online at no cost to you!
New Content
Treatment Considerations for Managing Dry Eye Secondary to Systemic Disease
Beyond Monotherapy: What the APL-3007 Combination Trial Signals About the Next Phase of Complement Therapy
The Logistics of Effective Collaborative Care for Glaucoma Management
Join Drs. Preeya K. Gupta, Matt Walker, and Deborah Ristvedt, as they discuss the implementation of collaborative care models for glaucoma management, highlighting the importance of trust and communication between ophthalmologists and referral optometrists.
The Digital Dilemma: Protecting Pediatric Vision in a Screen-Heavy World
Explore how optometrists can address the impact of screen exposure on myopia progression and educate parents and patients on healthy digital device use.
Why the Best Retina Surgeons Keep Adapting Their Technique
Join Drs. Kitchens and Sridhar as they discuss how cross-institutional training broadens surgeons' perspectives and improves patient care.
Topics
Redefining Durability in nAMD: How nAMD Clinical Trials are Evaluating Durability in New Ways
How Long-Term Durability and Safety are Redefining GA Treatment Decisions
Benchmarking Your Contact Lens KPIs: What Top-Performing Practices Are Tracking
Emerging Therapies and Clinical Trials in Early Diabetic Retinopathy
Spot the subtle signs of mild NPDR sooner, stage it with confidence, and know when watching and waiting stops serving your diabetic patients.
FDA approves Genentech's Enspryng as first at-home TED injection
Subcutaneous version of satralizumab-mwge can be administered by a patient or caregiver following training from an HCP.
Roche reports phase 3 data on steroid-free therapy for UME management
Company announces FDA acceptance of BLA submission as 52-week results find vamikibart demonstrated sustained improvements in vision.
Glaukos reports positive topline phase 4 data on iDose TR in combo with cataract surgery
Latest 3-month data demonstrate clinically meaningful IOP reductions compared to cataract surgery alone.
Beyond Monotherapy: What the APL-3007 Combination Trial Signals About the Next Phase of Complement Therapy
Join Drs. Rishi P. Singh and Mathew MacCumber as they discuss the clinical results of APL-3007 combined with pegcetacoplan for geographic atrophy (GA).
Assessing and Managing Retinal Tears as an Optometrist
Sit down with Drs. Daniel Epshtein and Jessica Haynes to review how to identify and stage retinal tears as well as decide when to refer high-risk cases.
Clinical Specialties
The Digital Dilemma: Protecting Pediatric Vision in a Screen-Heavy World
Why the Best Retina Surgeons Keep Adapting Their Technique
Benchmarking Your Contact Lens KPIs: What Top-Performing Practices Are Tracking
This article outlines which contact lens KPIs to track, how your optometry practice compares to industry benchmarks, and where to adjust to increase revenue.
Beyond the Sales Rep: Understanding Who’s Who in Industry
Discover who does what inside industry and how knowing the differences can save you time, find research opportunities, address insurance issues, and more.
I Saw It on TV: DTC Pharma Marketing and the New Eyecare Patient
Sit down with Drs. Lang, Garlich, and Dierker to review the impact of direct-to-consumer (DTC) pharmaceutical marketing on eyecare patients.
